Nono Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
NONO (Non-POU Domain Containing Octamer Binding) is a nuclear RNA-binding protein that plays essential roles in RNA processing, transcriptional regulation, and circadian rhythm control. It belongs to the Drosophila Behavior Human Splicing (DBHS) family and is implicated in several neurodegenerative diseases. [1]
| NONO Protein | |
|---|---|
| Protein Name | Non-POU Domain Containing Octamer Binding |
| Gene | [NONO](/genes/nono) |
| UniProt ID | [Q13435](https://www.uniprot.org/uniprot/Q13435) |
| PDB ID | 4RUM, 5O5B |
| Molecular Weight | 54 kDa |
| Subcellular Localization | Nucleus (speckles, paraspeckles) |
| Protein Family | DBHS family |
NONO contains two RNA recognition motifs (RRMs) in the central region and a coiled-coil domain for dimerization at the C-terminus. The protein forms heterodimers with other DBHS family members:
These heterodimers are the functional units involved in RNA processing.
NONO participates in multiple nuclear processes:
Mutations in NONO are linked to ALS and frontotemporal dementia (FTD):
Nono Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Nono Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Kowalska M, Bartoszewska H, Szewczyk L, et al. NONO regulates circadian rhythm and metabolism (2016). 2016. ↩︎